| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/04/2004 | WO2004018472A2 Pyrimido compounds having antiproliferative activity |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 03/04/2004 | WO2004018419A2 Benzimidazole quinolinones and uses thereof |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods |
| 03/04/2004 | WO2004018044A2 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 03/04/2004 | WO2004018043A1 A pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease |
| 03/04/2004 | WO2004018000A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents |
| 03/04/2004 | WO2004017992A2 Ptk7 protein involvement in carcinoma |
| 03/04/2004 | WO2004017991A1 Use of iap for the diagnosis and of iap-inhibitors for the treatment of hodgkin’s lymphomas |
| 03/04/2004 | WO2004017987A2 Heterocarpin, a plant-derived protein with anti-cancer properties |
| 03/04/2004 | WO2004017981A1 Extraction method for effectively obtaining amygdalin from persicae semen or armeniacae semen |
| 03/04/2004 | WO2004017964A1 Combination therapy for hyperproliferative diseases |
| 03/04/2004 | WO2004017959A2 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 03/04/2004 | WO2004017958A1 Soft capsule preparation |
| 03/04/2004 | WO2004017940A2 Pharmaceutically active lipid based formulation of sn38 |
| 03/04/2004 | WO2004017937A1 Biodegradable composition with prolonged release of the biological active compound and preparation thereof |
| 03/04/2004 | WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2004001059A3 Heterocyclic inhibitors of kinases |
| 03/04/2004 | WO2004000229A3 Treatment of human multiple myeloma by curcumin |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003105908A9 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003083485A3 Protein for use in hypoxia related conditions |
| 03/04/2004 | WO2003078646A3 Aza-thioxanthenones with antitumor activity |
| 03/04/2004 | WO2003077855A3 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003062830A3 Fibronectin variants and screening methods |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003049527A3 Mitotic kinesin inhibitors |
| 03/04/2004 | WO2003048207A3 Anti-dota antibody |
| 03/04/2004 | WO2003042214A3 A2b adenosine receptor antagonists |
| 03/04/2004 | WO2003039466A8 Method of treating estrogen responsive breast cancer |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003032916A3 Organosulfur inhibitors of tyrosine phosphatases |
| 03/04/2004 | WO2003028642A9 Methods of inhibiting metastases |
| 03/04/2004 | WO2003026581A3 Pharmaceutical compositions and methods for treating cancer |
| 03/04/2004 | WO2003025176A8 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 03/04/2004 | WO2003024928A3 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 03/04/2004 | WO2003022844A3 Synthesis of epothilones intermediates thereto and analogues thereof |
| 03/04/2004 | WO2003016348A3 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 03/04/2004 | WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces |
| 03/04/2004 | WO2003013430A3 Benzoquinone ansamycins |
| 03/04/2004 | WO2003005961A3 A controlled release biodegradable gel matrix |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002085459A3 Antiangiogenic combination therapy for the treatment of cancer |
| 03/04/2004 | WO2002022134A8 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044197 Fluorinated photosensitizers related to chlorins and bacteriochlorins for photodynamic therapy |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040044058 Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same |
| 03/04/2004 | US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044034 Tyrosine kinase inhibitor; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040044015 Quinazoline derivatives |
| 03/04/2004 | US20040044013 Antiarthritic agents; side effect reduction |
| 03/04/2004 | US20040044010 Central nervous system disorders; Alzheimer's disease; Parkinson's disease |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043966 Using 1-hydroxy-2-(imidazolo(1,2-a)pyridin-3-yl)ethanediphosphonic acid; bone disorders |
| 03/04/2004 | US20040043965 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| 03/04/2004 | US20040043962 Method for enhancing the effectiveness of cancer therapies |
| 03/04/2004 | US20040043959 Combination therapies for treating methylthioadenosine phosphorylase deficient cells |
| 03/04/2004 | US20040043936 Antiproliferative and antiviral proteins and peptides |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043918 Containing phosphatides; killing cancer, tumor cells |
| 03/04/2004 | US20040043470 Regulation of human histone deacetylase |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043375 Regulation of human serine-threonine protein kinase |
| 03/04/2004 | US20040043083 Anticancer composition comprising sesquiterpenes isolated from resina ferulae |
| 03/04/2004 | US20040043076 Containing protein active material; solvent-free |
| 03/04/2004 | US20040043074 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 03/04/2004 | US20040043063 In situ transfection; gene therapy; protein in liposome capsules |
| 03/04/2004 | US20040043040 SDF-1 beta tumor vaccines and uses therefor |
| 03/04/2004 | US20040043002 Polyol-IFN-beta conjugate and composition containing same |
| 03/04/2004 | US20040043001 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same |
| 03/04/2004 | DE10239042A1 New fused macrocyclic pyrimidine derivatives, useful as e.g. cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections |
| 03/04/2004 | DE10238169A1 Verfahren zur vereinfachten Herstellung einer Zusammensetzung mit hohem Avarolgehalt mit verbesserter Wirkung sowie dessen Verwendung zur Behandlung proliferativer Funktionsstörungen oder zur Herstellung von reinem Avarol und Avaron hieraus A process for the simplified preparation of a composition with a high Avarolgehalt having improved activity and the use thereof for treating proliferative disorders or for preparing pure avarol and avarone thereof |
| 03/04/2004 | DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 03/04/2004 | CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system |
| 03/04/2004 | CA2496781A1 Methods for treating patients and identifying therapeutics |